<SEC-DOCUMENT>0001104659-20-007806-index.html : 20200129
<SEC-HEADER>0001104659-20-007806.hdr.sgml : 20200129
<ACCEPTANCE-DATETIME>20200129060603
ACCESSION NUMBER:		0001104659-20-007806
CONFORMED SUBMISSION TYPE:	S-1MEF
PUBLIC DOCUMENT COUNT:		4
<REFERENCE-462B>333-232529
FILED AS OF DATE:		20200129
DATE AS OF CHANGE:		20200129
EFFECTIVENESS DATE:		20200129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Annovis Bio, Inc.
		CENTRAL INDEX KEY:			0001477845
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262540421
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1MEF
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-236126
		FILM NUMBER:		20556266

	BUSINESS ADDRESS:	
		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
		CITY:			BERWYN
		STATE:			PA
		ZIP:			19312
		BUSINESS PHONE:		610-727-3913

	MAIL ADDRESS:	
		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
		CITY:			BERWYN
		STATE:			PA
		ZIP:			19312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QR Pharma, Inc.
		DATE OF NAME CHANGE:	20091202
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1MEF
<SEQUENCE>1
<FILENAME>a19-9635_14s1mef.htm
<DESCRIPTION>S-1MEF
<TEXT>
Document 1 - file: a19-9635_14s1mef.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>a19-9635_14ex5d1.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: a19-9635_14ex5d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>a19-9635_14ex23d1.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: a19-9635_14ex23d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g963513kii001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g963513kii001.jpg

</DOCUMENT>
</SEC-DOCUMENT>